Tas Faruk
Institute of Oncology, University of Istanbul, Capa, 34390, Istanbul, Turkey,
Tumour Biol. 2014 May;35(5):4645-9. doi: 10.1007/s13277-014-1608-7. Epub 2014 Jan 12.
The most-cited papers (MCPs) are likely those that impressed researchers and had profound influence on clinical practice or future developments in the related scientific field. This study was conducted to explore a bibliometric approach to assess where the oncology-related MCPs have been published in. The source of the data presented in this study was provided by using the InCitesTM, Web of Science, Thomson Reuters Database (2013). It contained any journal indexed by ISI between 1979 and 2013. The term MCPs arbitrarily defined as equal or more than 100 citations. A total of 565 publications were cited equal or more than 100 times. They were published in 79 different journals (64 oncology, 12 medicine, and 3 science), led by the Journal of Clinical Oncology (n = 76; 13.5%) and Cancer Research (n = 66; 11.7%) followed by Oncogene (n = 46; 8.1%), Nature Reviews Cancer (n = 41; 7.3%), and Cancer (n = 37; 6.5%). Moreover, the journal categories with the MCPs were the Oncology with 495 articles (87.6%), followed by the Medicine with 60 (10.6%) articles. However, the numbers of journals related to Science (n = 10; 1.8%) were the least. The MCPs were cited a total of 118,531 times. The citations ranged from 100 to 1,790, and the median number was 149. The total numbers of MCPs were the most prominent for the journals, the New England Journal of Medicine (median 398), Lancet (median 213), and Nature Reviews Cancer (median 210). In other side, the counts of MCPs were the highest for the Science and Medicine-categorized journals (median 212.5 and 192.5 citations, respectively). The MCPs categorized as Oncology were the least cited (median 145). The median number of MCPs per year was 18.7 with range 4.1-858.5. The annual most valuable MCPs were also published in the journal Nature Reviews Cancer (median 42) and the New England Journal of Medicine (median 38.7). Likewise, the numbers of MCPs were the highest for the Science-categorized journals (median 37), whereas the citations per year were significantly lower in Medicine and Oncology-categorized journals (25.8 and 17.8, respectively). In conclusion, most of the MCPs were published in Oncology specialized journals.
被引用次数最多的论文（MCPs）可能是那些给研究人员留下深刻印象并对临床实践或相关科学领域的未来发展产生深远影响的论文。本研究旨在探索一种文献计量学方法，以评估肿瘤学相关的MCPs发表在哪些地方。本研究中呈现的数据来源是使用InCitesTM、科学网、汤森路透数据库（2013年）提供的。它包含了1979年至2013年期间被ISI索引的任何期刊。MCPs一词被任意定义为被引用100次及以上。共有565篇出版物被引用100次及以上。它们发表在79种不同的期刊上（64种肿瘤学期刊、12种医学期刊和3种科学期刊），以《临床肿瘤学杂志》（n = 76；13.5%）和《癌症研究》（n = 66；11.7%）为首，其次是《癌基因》（n = 46；8.1%）、《自然评论·癌症》（n = 41；7.3%）和《癌症》（n = 37；6.5%）。此外，有MCPs的期刊类别中，肿瘤学有495篇文章（87.6%），其次是医学有60篇文章（10.6%）。然而，与科学相关的期刊数量最少（n = 10；1.8%）。这些MCPs总共被引用了118,531次。引用次数从100到1790不等，中位数为149。MCPs总数在《新英格兰医学杂志》（中位数398）、《柳叶刀》（中位数213）和《自然评论·癌症》（中位数210）等期刊中最为突出。另一方面，科学和医学类期刊的MCPs数量最多（中位数分别为212.5和192.5次引用）。归类为肿瘤学的MCPs被引用次数最少（中位数145）。每年MCPs的中位数为18.7，范围为4.1 - 858.5。每年最有价值的MCPs也发表在《自然评论·癌症》杂志（中位数42）和《新英格兰医学杂志》（中位数38.7）上。同样，科学类期刊的MCPs数量最多（中位数37），而医学和肿瘤学类期刊每年的引用次数明显较低（分别为25.8和17.8）。总之，大多数MCPs发表在肿瘤学专业期刊上。
